Aspirin for Prevention of Cardiovascular Disease
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Aspirin for Prevention of Cardiovascular Disease
  • Published Date:

    Sep 07 2017

  • Source:
    Prev Chronic Dis. 14.
Filetype[PDF-223.70 KB]


Details:
  • Alternative Title:
    Prev Chronic Dis
  • Description:
    We used data from the 2013 Mississippi Behavioral Risk Factor Surveillance System to examine aspirin use for the prevention of primary and secondary cardiovascular disease (CVD), based on the 2009 US Preventive Services Task Force (USPSTF) guidelines, among Mississippi men (aged 45-79 y) and women (aged 55-79 y) and to explore differences in aspirin use by sociodemographic characteristics. Among those without CVD, 39.1% of men and 45.9% of women reported taking aspirin, and among those with CVD, 85.9% of men and 85.1% of women reported taking aspirin. Data on preventive use of aspirin by sociodemographic characteristics yielded mixed results.
  • Subject:
  • Pubmed ID:
    28880838
  • Pubmed Central ID:
    PMC5590489
  • Document Type:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: